indapamide has been researched along with Syndrome in 1 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a 50-year-old hypertensive woman on Indapamide presenting with malaise, dizziness and serum sodium less than 100mmol/l who developed osmotic demyelination syndrome after correction of the hyponatremia." | 3.91 | Plasmapheresis to treat Osmotic Demyelination Syndrome from overly rapid plasma sodium correction. ( Chia, YK; Dhayalen, K; Fung, YK; Gayathri, DK, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gayathri, DK | 1 |
| Dhayalen, K | 1 |
| Chia, YK | 1 |
| Fung, YK | 1 |
1 other study available for indapamide and Syndrome
| Article | Year |
|---|---|
Plasmapheresis to treat Osmotic Demyelination Syndrome from overly rapid plasma sodium correction.
Topics: Antihypertensive Agents; Biomarkers; Demyelinating Diseases; Female; Humans; Hyponatremia; Indapamid | 2019 |